Search - tctmd.com

Displaying 161 - 180 of 708

Sort: Relevancy | Date

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Devices: Reimbursement Considerations

Presenter: Lori Ashby

September 27, 2019

Presentation TCT 2019

Leaflet Technologies I: Pascal — Device Description, Results, and Ongoing Studies

Presenter: Scott Lim

September 27, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Regulatory Considerations

Presenter: Changfu Wu

September 27, 2019

Presentation TCT 2019

Leaflet Technologies and Chordal Replacement: Surgical Lessons Learned

Presenter: Marc Gillinov

September 27, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Industry Perspectives

Presenter: Ted Feldman

September 27, 2019

Presentation TCT 2019

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

Presenter: Gregg Stone

September 27, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

Presentation TCT 2019

ICE Guidance as the Primary Strategy for LAA Closure: Technique and Data

Presenter: Mohamad Alkhouli

September 27, 2019

Presentation TCT 2019

Utility of CT for Pre-Procedural Planning and Device Selection

Presenter: Michael Rinaldi

September 27, 2019

Presentation TCT 2019

Choosing the “Right” TAVR System for Your Patients: A Multi-Device, Anatomy-Specific Approach

Presenter: Howard Herrmann

September 27, 2019

Presentation TCT 2019

Reimbursement Pathways for Shock Devices

Presenter: Lori Ashby

September 27, 2019

Presentation TCT 2019

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Presenter: Anthony Gershlick

September 27, 2019

Presentation TCT 2019

Case-Based Device Selection: Matching the Device With the Anatomy

Presenter: Reda Ibrahim

September 27, 2019

Presentation TCT 2019

Industry Perspectives on Controlled Trials for Shock Devices

Presenter: Seth Bilazarian

September 27, 2019

Presentation TCT 2019

Devices to Treat Shock: Regulatory Perspectives

Presenter: Fernando Aguel

September 27, 2019

Presentation TCT 2019

Keynote Lecture: The Spectrum of LAA Closure Technology — Current and Emerging Devices

Presenter: Horst Sievert

September 27, 2019

Presentation TCT 2019

Perspectives on Infarct Size as a Surrogate in STEMI

Presenter: Navin Kapur

September 27, 2019

Presentation TCT 2019

Industry View on Controlled Trials for Heart Failure and Shock Devices

Presenter: William Abraham

September 27, 2019

Presentation TCT 2019

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Presenter: Kishore Harjai

September 27, 2019

Presentation TCT 2019

ARC Initiative for Heart Failure and Shock: HF ARC, Shock ARC, and More

Presenter: Christopher O'Connor

September 27, 2019

Advertisement

Transcatheter Mitral Valve Repair and Replacement Devices: Reimbursement Considerations

Leaflet Technologies I: Pascal — Device Description, Results, and Ongoing Studies

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Regulatory Considerations

Leaflet Technologies and Chordal Replacement: Surgical Lessons Learned

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Industry Perspectives

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

ICE Guidance as the Primary Strategy for LAA Closure: Technique and Data

Utility of CT for Pre-Procedural Planning and Device Selection

Choosing the “Right” TAVR System for Your Patients: A Multi-Device, Anatomy-Specific Approach

Reimbursement Pathways for Shock Devices

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Case-Based Device Selection: Matching the Device With the Anatomy

Industry Perspectives on Controlled Trials for Shock Devices

Devices to Treat Shock: Regulatory Perspectives

Keynote Lecture: The Spectrum of LAA Closure Technology — Current and Emerging Devices

Perspectives on Infarct Size as a Surrogate in STEMI

Industry View on Controlled Trials for Heart Failure and Shock Devices

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

ARC Initiative for Heart Failure and Shock: HF ARC, Shock ARC, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content